Mexiletine: An adjuvant option for refractory pain in patients with sickle cell disease and comorbid autism spectrum disorder

Early View e29526

LETTER TO THE EDITOR

Nour K. Kadouh,

Nour K. Kadouh

Department of Clinical Pharmacy, University of Michigan College of Pharmacy, Ann Arbor, Michigan, USA

Contributed equally.

Search for more papers by this authorStacy Lang,

Stacy Lang

Department of Pediatrics, University of Michigan Medical School, Ann Arbor, Michigan, USA

Contributed equally.

Search for more papers by this authorMark Shamoun,

Mark Shamoun

Department of Pediatrics, University of Michigan Medical School, Ann Arbor, Michigan, USA

Search for more papers by this authorEric L. Scott,

Eric L. Scott

Departments of Pediatrics and Anesthesiology, University of Michigan Medical School, Ann Arbor, Michigan, USA

Search for more papers by this authorSharon A. Singh,

Sharon A. Singh

Department of Pediatrics, University of Michigan Medical School, Ann Arbor, Michigan, USA

Search for more papers by this authorMichael A. Smith,

Corresponding Author

Michael A. Smith

Department of Clinical Pharmacy, University of Michigan College of Pharmacy, Ann Arbor, Michigan, USA

Correspondence

Michael A. Smith, Department of Clinical Pharmacy, University of Michigan College of Pharmacy, Adult Palliative Care, F7870 UH South, 1500 E. Medical Center Drive, Ann Arbor, MI 48109, USA.

Email: mandsmit@med.umich.edu

Search for more papers by this author PDFPDF Please review our Terms and Conditions of Use and check box below to share full-text version of article.

I have read and accept the Wiley Online Library Terms and Conditions of Use

Shareable Link

Use the link below to share a full-text version of this article with your friends and colleagues. Learn more.

Share a link

Share on

No abstract is available for this article.

留言 (0)

沒有登入
gif